Authors
Dale Porter, PhD, is the vice president, head of US oncology and immuno-oncology research at Servier, a global pharmaceutical group with a long-term approach to drug discovery and oncology research and development.
Patricia Hayes, MD, is an internal medicine physician and Texas Area Medical Director for CenterWell.
Robert Pittman is senior vice president of government affairs at Modivcare, a technology-enabled health care services company that provides a platform of integrated supportive care solutions.
Jay Anders, MD, has been chief medical officer at Medicomp Systems since August of 2014.
Dani Castillo, MD, medical oncologist, City of Hope.
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
3
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
4
Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits
5

